y 27632 has been researched along with dinoprost in 6 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (dinoprost) | Trials (dinoprost) | Recent Studies (post-2010) (dinoprost) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 11,554 | 940 | 1,936 |
| Protein | Taxonomy | y 27632 (IC50) | dinoprost (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.0025 | |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | 0.0713 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.14 | |
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.3 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.14 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 4.2 | |
| Prostaglandin F2-alpha receptor | Bos taurus (cattle) | 0.14 | |
| Prostaglandin F2-alpha receptor | Homo sapiens (human) | 0.0139 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.216 | |
| Prostaglandin D2 receptor | Homo sapiens (human) | 4.5 | |
| Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.287 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janssen, LJ; Miller, J; Tazzeo, T | 1 |
| Kawagishi, R; Morishige, K; Murata, Y; Sakata, M; Sawada, K; Tahara, M; Tasaka, K | 1 |
| Friel, AM; Morrison, JJ; O'reilly, MW; Sexton, DJ; Smith, TJ | 1 |
| Hashiba, Y; Imai, H; Saito, N; Sasaki, T; Shimizu, T; Tosaka, M | 1 |
| Honjo, H; Ito, S; Kamiya, K; Kume, H; Makino, Y; Oguma, T; Shimokata, K; Shiraki, A | 1 |
| Almeida-Reis, R; Charafeddine, HT; da Silva, PA; Leick-Maldonado, EA; Martins, MA; Perini, A; Possa, SS; Prado, CM; Righetti, RF; Saraiva-Romanholo, BM; Tibério, Ide F | 1 |
6 other study(ies) available for y 27632 and dinoprost
| Article | Year |
|---|---|
Vasoconstrictor responses, and underlying mechanisms, to isoprostanes in human and porcine bronchial arterial smooth muscle.
Topics: Alprostadil; Amides; Animals; Bronchial Arteries; Dinoprost; Dinoprostone; Dioxanes; Dose-Response Relationship, Drug; F2-Isoprostanes; Genistein; Humans; Isoprostanes; Muscle, Smooth, Vascular; Prostaglandins E; Prostaglandins F, Synthetic; Pyridines; Receptors, Thromboxane A2, Prostaglandin H2; Signal Transduction; Swine; Vasoconstriction; Vasoconstrictor Agents | 2003 |
Tocolytic effect of a Rho-kinase inhibitor in a mouse model of lipopolysaccharide-induced preterm delivery.
Topics: Amides; Animals; Cells, Cultured; Dinoprost; Disease Models, Animal; Enzyme Inhibitors; Female; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Mice; Mice, Inbred C3H; Obstetric Labor, Premature; Pregnancy; Protein Serine-Threonine Kinases; Pyridines; rho-Associated Kinases; Tocolytic Agents | 2005 |
Rho A/Rho kinase: human umbilical artery mRNA expression in normal and pre eclamptic pregnancies and functional role in isoprostane-induced vasoconstriction.
Topics: Acute-Phase Proteins; Amides; Analysis of Variance; Case-Control Studies; Dinoprost; Dinoprostone; Female; Humans; Intracellular Signaling Peptides and Proteins; Isoprostanes; Muscle, Smooth, Vascular; Pre-Eclampsia; Pregnancy; Protein Isoforms; Protein Serine-Threonine Kinases; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; RNA, Messenger; Tissue Culture Techniques; Umbilical Arteries; Vasoconstrictor Agents | 2006 |
Vasorelaxing effect of the Rho-kinase inhibitor, Y-27632, in isolated canine basilar arteries.
Topics: Amides; Animals; Basilar Artery; Calcium; Dinoprost; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Myosin Light Chains; Phosphorylation; Phosphorylcholine; Pyridines; Sphingosine; Vasodilation | 2007 |
Role of Ca2+ mobilization and Ca2+ sensitization in 8-iso-PGF 2 alpha-induced contraction in airway smooth muscle.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amides; Animals; Bridged-Ring Compounds; Calcium Channel Blockers; Calcium Signaling; Diltiazem; Dinoprost; Dioxanes; Enzyme Inhibitors; Estrenes; Guinea Pigs; Imidazoles; In Vitro Techniques; Indoles; Male; Maleimides; Muscle Contraction; Muscle, Smooth; Norbornanes; Pyridines; Pyrrolidinones; Receptors, Thromboxane A2, Prostaglandin H2; rho-Associated Kinases; Signal Transduction; Thiocarbamates; Thiones; Trachea; Type C Phospholipases; Vasoconstrictor Agents; Verapamil | 2009 |
Rho-kinase inhibition attenuates airway responsiveness, inflammation, matrix remodeling, and oxidative stress activation induced by chronic inflammation.
Topics: Airway Remodeling; Airway Resistance; Amides; Animals; Anti-Asthmatic Agents; Asthma; Collagen; Dinoprost; Drug Evaluation, Preclinical; Elastic Tissue; Elasticity; Eosinophils; Extracellular Matrix; Guinea Pigs; Inhalation; Interleukin-2; Lung; Male; Matrix Metalloproteinase 9; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Pyridines; rho-Associated Kinases | 2012 |